BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 34707803)

  • 21. Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe.
    Shrestha S; Giri R; Sapkota HP; Danai SS; Saleem A; Devkota S; Shrestha S; Adhikari B; Poudel A
    Ther Adv Drug Saf; 2021; 12():20420986211019309. PubMed ID: 34211689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are residents of aged care facilities willing to have their medications deprescribed?
    Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
    Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists.
    Lukacena KM; Keck JW; Freeman PR; Harrington NG; Huffmyer MJ; Moga DC
    Ther Adv Drug Saf; 2022; 13():20420986221116465. PubMed ID: 36003624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
    Thillainadesan J; Gnjidic D; Green S; Hilmer SN
    Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Implications of Potentially Inappropriate Prescribing According to STOPP/START Version 2 Criteria in Older Polymorbid Patients Discharged From Geriatric and Internal Medicine Wards: A Prospective Observational Multicenter Study.
    Brunetti E; Aurucci ML; Boietti E; Gibello M; Sappa M; Falcone Y; Cappa G; Bo M
    J Am Med Dir Assoc; 2019 Nov; 20(11):1476.e1-1476.e10. PubMed ID: 31109910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
    Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
    J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deprescribing opportunities for elderly inpatients in an academic, safety-net health system.
    Bredhold BE; Deodhar KS; Davis CM; DiRenzo BM; Isaacs AN; Campbell NL
    Res Social Adm Pharm; 2021 Mar; 17(3):541-544. PubMed ID: 32402730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electronic Decision Support for Deprescribing in Patients on Hemodialysis: Clinical Research Protocol for a Prospective, Controlled, Quality Improvement Study.
    Bortolussi-Courval É; Podymow T; Trinh E; Moryousef J; Hanula R; Huon JF; Mavrakanas T; Suri R; Lee TC; McDonald EG
    Can J Kidney Health Dis; 2023; 10():20543581231165712. PubMed ID: 37435299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.
    Galazzi A; Lusignani M; Chiarelli MT; Mannucci PM; Franchi C; Tettamanti M; Reeve E; Nobili A
    Int J Clin Pharm; 2016 Apr; 38(2):454-61. PubMed ID: 26951120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med study.
    Etherton-Beer C; Page A; Naganathan V; Potter K; Comans T; Hilmer SN; McLachlan AJ; Lindley RI; Mangin D
    Age Ageing; 2023 May; 52(5):. PubMed ID: 37247404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple medication use in older patients in post-acute transitional care: a prospective cohort study.
    Runganga M; Peel NM; Hubbard RE
    Clin Interv Aging; 2014; 9():1453-62. PubMed ID: 25214773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing deprescribing tools for implementation in care homes: A qualitative study of the views of care home staff.
    Warmoth K; Rees J; Day J; Cockcroft E; Aylward A; Pollock L; Coxon G; Craig T; Walton B; Stein K
    Res Social Adm Pharm; 2024 Apr; 20(4):379-388. PubMed ID: 38245383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deprescribing in Frail Older People: A Randomised Controlled Trial.
    Potter K; Flicker L; Page A; Etherton-Beer C
    PLoS One; 2016; 11(3):e0149984. PubMed ID: 26942907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.